The Saudi Food and Drug Authority (SFDA) has announced call for abstracts for the 6th Regulatory Science Research Day, aimed at bolstering evidence-based healthcare policy and clinical trial regulation.
The initiative follows a 83% increase in clinical trial applications in Saudi Arabia and expanded fast-track designations for orphan and breakthrough biopharmaceutical drugs.